Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Feb 4;128(5):597–598. doi: 10.1016/j.anai.2022.01.041

A pediatric asthma camp experience during the coronavirus disease 2019 pandemic

Victoria Eng 1, Gary Paul Moreno 1, Jinny Chang 1, Myron Liebhaber 1
PMCID: PMC8813763  PMID: 35131411

Every year, Camp Wheez is offered as a free summer day camp for children with asthma. Because of the ongoing coronavirus disease 2019 (COVID-19) pandemic, Camp Wheez 2020 was canceled. For 2021, we adapted Camp Wheez to the guidelines for summer camps put forth by the Centers for Disease Control and Prevention.1

The primary aim of this study was to describe our experience with having a 4-day educational asthma program for children during the COVID-19 pandemic. Secondary aims were to investigate the effect of our educational program on airway inflammation and expiratory air flow from the lungs as measured by fractional exhaled nitric oxide (FENO) and peak flow (PF), respectively.

Since 1978, Camp Wheez has been a free annual day camp every August for children with asthma. Camp Wheez 2021 was open to all children with asthma aged 6 to 10 years of age, a reduced age range as compared with previous years to decrease gathering size. Camp Wheez 2021 reduced its capacity by half and decreased duration from 5 to 4 days to further decrease exposure and infection risk for campers. Written informed consent was obtained for each camper. All counselors and staff were required to be vaccinated for COVID-19 before the camp. Camp Wheez 2021 was conducted in accordance with the guidance of the Centers for Disease Control and Prevention for day camps: all activities were conducted outdoors, all campers and staff masked and maintained a physical distance of at least 6 feet, campers were cohorted into groups of 3 to 4 children to avoid mixing, campers were curbside-dropped off by parents to reduce the possible number of contacts, hand-sanitizing was enforced at the beginning and end of each rotation activity, point persons were designated to respond to any COVID-19 concerns, and all participants were counseled by health care staff to stay home for any COVID-19 symptoms.1 Follow-up screening questionnaires for COVID-19 symptoms were done 1 week after camp completion. The NIOX Vero was used to measure FENO on day 1 (pre-camp), day 4 (post-camp), and approximately 1 week after the camp (follow-up). PFs were measured daily at the camp.

Wilcoxon signed rank test was used to compare mean FENOs pre-camp and post-camp. A one-way analysis of variance was used to compare mean peak flows between days 1 and 4 of the camp. We took P < 0"?>.05 to indicate statistical significance.

A total of 20 children aged 6 to 10 years old were enrolled in Camp Wheez 2021, and the average age of the campers was 8.5 ± 1.3 years.

None of the children developed COVID-19 symptoms for the entire duration of the camp. All follow-up screening questionnaires, done approximately 1 week after camp completion, were negative for COVID-19 symptoms. There were no statistically significant differences in mean FENO between pre- and post-camp (P = 0"?>.984, Table 1 ). There was no statistically significant difference in mean peak flows among the days at the camp (P = 0"?>.744, Table 1). Campers were not informed of their baseline FENO nor PF and none of the campers received targeted instruction.

Table 1.

Camper Demographics with Pre-Camp and Post-Camp FENO and Daily PF Measurements

Campers (n) 20
Mean age, y +/−SEM 8.5 +/−1.3
Mean pre-camp FENO,
ppb +/−SEM
22.1 +/−4.8
Mean post-camp FENO,
ppb +/−SEM
22.2 +/−5.3
Mean Day 1 mean PF,
L/min +/−SEM
254 +/−15
Mean Day 2 mean PF,
L/min +/−SEM
249 +/−16
Mean Day 3 mean PF,
L/min +/−SEM
273 +/−18
Mean Day 4 mean PF,
L/min +/−SEM
267 +/−18

The COVID-19 pandemic has required flexibility to adapt to the ever-changing environment. Social gatherings, including children's day camps, have been affected and require the development of safe procedures and protocols. Although a virtual platform was considered, the concern for screen fatigue was raised.2 None of the campers developed COVID-19 symptoms throughout the camp duration nor at the 1 week follow-up questionnaire, though the community prevalence of COVID-19 during early August 2021 was a daily case rate of 18.6 per 100,000 people in Santa Barbara County, which may be lower as compared with other points during the ongoing pandemic.3 Although we did not see a statistically significant difference in FENO nor PF before and after the camp, the feedback and gratitude we received from both parents and campers make continuing Camp Wheez a worthy annual effort.

This is one of the first studies looking at the feasibility of a pediatric asthma camp during the COVID-19 pandemic, with objective measures to evaluate the camp's effect on campers’ airway status. FENO has been found to decrease in children who attend summer asthma camps.4 The low mean baseline FENO could represent potentially improved asthma control, reduced triggers, and medication adherence during the COVID-19 pandemic.5

Our study should be interpreted in the context of several potential limitations. The small sample size and short duration of the camp may not have been sufficiently powered to detect a statistically significant difference in FENO and PF or to prove an asthma camp does not increase the risk of COVID-19 infection for our campers. Although all counselors and staff were vaccinated against COVID-19, testing was not required, so asymptomatic infection may have gone undetected. Rapid testing for COVID-19 was not readily available at the time of Camp Wheez 2021. Dependence on reported symptoms and questionnaires reflects subjective rather than objective measures for COVID-19 incidence.

We share our experience of having an educational asthma program for children during the COVID-19 pandemic, though no differences in FENO or peak flow were noted between groups. We strive to provide a balance of providing resources for our children with asthma while ensuring safety by following public health guidance. We wanted to be able to offer a much-loved experience for our children with asthma but, understandably, the COVID-19 pandemic will make certain experiences impossible to replicate as compared with before. The risks and benefits must always be weighed on an ongoing basis during the ever-changing climate of the COVID-19 pandemic.

Footnotes

Disclosures: The authors have no conflicts of interest to report.

Funding: This study was funded by the Circassia grant and Sansum Clinic Foundation.

References


Articles from Annals of Allergy, Asthma & Immunology are provided here courtesy of Elsevier

RESOURCES